best mid or large cap stock q3 2022

Rhythm Pharmaceuticals (RYTM) had the highest return in Q3 2022 by a US stock with a market cap of $2B+, returning 500.5%.

ASSETQUARTER% RETURN
Rhythm Pharmaceuticals (RYTM)
Q3 2022
500.49%
Akero Therapeutics (AKRO)
Q3 2022
251.76%
Terns Pharmaceuticals (TERN)
Q3 2022
139.43%
Avadel Pharmaceuticals (AVDL)
Q3 2022
104.49%
First Solar (FSLR)
Q3 2022
95.72%
YPF Sociedad Anonima (YPF)
Q3 2022
90.49%
Dyne Therapeutics  (DYN)
Q3 2022
84.59%
Catalyst Pharmaceuticals (CPRX)
Q3 2022
83.55%
Calix (CALX)
Q3 2022
80.94%
Viridian Therapeutics (VRDN)
Q3 2022
76.81%
Cogent Biosciences (COGT)
Q3 2022
70.51%
Xometry (XMTR)
Q3 2022
67.77%
Wingstop (WING)
Q3 2022
66.86%
International Seaways (INSW)
Q3 2022
66.56%
Centrus Energy (LEU)
Q3 2022
65.58%
Riot Blockchain (RIOT)
Q3 2022
65.33%
Genius Sports (GENI)
Q3 2022
63.84%
Bel Fuse B (BELFB)
Q3 2022
62%
Applied Digital (APLD)
Q3 2022
58.88%
Vera Therapeutics (VERA)
Q3 2022
56.58%
Fluence Energy (FLNC)
Q3 2022
54.39%
Payoneer Global (PAYO)
Q3 2022
53.55%
CommScope (COMM)
Q3 2022
52.74%
Penumbra (PEN)
Q3 2022
52.42%
Weatherford International (WFRD)
Q3 2022
52.38%